AI assistant
Sending…
Merck & Co., Inc. — Director's Dealing 2014
May 13, 2014
284_dirs_2014-05-13_ada8ad77-4ef8-4f71-8acd-b54a4244314b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Merck & Co. Inc. (MRK)
CIK: 0000310158
Period of Report: 2014-05-09
Reporting Person: Karachun Rita A (Sr. VP Fince-Global Controller)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-05-09 | Restricted Stock Unit | $ | A | 2576.0000 | Acquired | 2017-05-09 | Common Stock (2576.0000) | Direct |
| 2014-05-09 | Stock Option (right to buy) | $58.2200 | A | 27510.0000 | Acquired | 2024-05-08 | Common Stock (27510.0000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 10419.5660 | Direct |
Footnotes
F1: Holdings include shares acquired in dividend reinvestment transactions.
F2: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
F3: The option vests in three equal annual installments beginning May 9, 2015.
More from Merck & Co., Inc.
Regulatory Filings
2026
May 29
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 4
Major Shareholding Notification
2026
Apr 30
Regulatory Filings
2026
Apr 30